These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 15895377

  • 1. CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer.
    Zhao H, Shiina H, Greene KL, Li LC, Tanaka Y, Kishi H, Igawa M, Kane CJ, Carroll P, Dahiya R.
    Cancer; 2005 Jul 01; 104(1):44-52. PubMed ID: 15895377
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
    Enokida H, Shiina H, Igawa M, Ogishima T, Kawakami T, Bassett WW, Anast JW, Li LC, Urakami S, Terashima M, Verma M, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R.
    Cancer Res; 2004 Sep 01; 64(17):5956-62. PubMed ID: 15342374
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP, Harya NS, Hutzley J, Bacich DJ, Monzon FA, Chandran U, Dhir R, O'Keefe DS.
    Prostaglandins Other Lipid Mediat; 2007 Jan 01; 82(1-4):185-97. PubMed ID: 17164146
    [Abstract] [Full Text] [Related]

  • 7. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y, Kyprianou N.
    Cancer Res; 1999 Mar 15; 59(6):1366-71. PubMed ID: 10096572
    [Abstract] [Full Text] [Related]

  • 8. CpG hypermethylation of the promoter region inactivates the estrogen receptor-beta gene in patients with prostate carcinoma.
    Nojima D, Li LC, Dharia A, Perinchery G, Ribeiro-Filho L, Yen TS, Dahiya R.
    Cancer; 2001 Oct 15; 92(8):2076-83. PubMed ID: 11596023
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells.
    Lu S, Dong Z.
    Prostate; 2006 Jun 15; 66(9):996-1004. PubMed ID: 16541418
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Methylation mediated silencing of TMS1/ASC gene in prostate cancer.
    Das PM, Ramachandran K, Vanwert J, Ferdinand L, Gopisetty G, Reis IM, Singal R.
    Mol Cancer; 2006 Jul 18; 5():28. PubMed ID: 16848908
    [Abstract] [Full Text] [Related]

  • 14. Frequent methylation of estrogen receptor in prostate cancer: correlation with tumor progression.
    Li LC, Chui R, Nakajima K, Oh BR, Au HC, Dahiya R.
    Cancer Res; 2000 Feb 01; 60(3):702-6. PubMed ID: 10676656
    [Abstract] [Full Text] [Related]

  • 15. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer.
    Tokizane T, Shiina H, Igawa M, Enokida H, Urakami S, Kawakami T, Ogishima T, Okino ST, Li LC, Tanaka Y, Nonomura N, Okuyama A, Dahiya R.
    Clin Cancer Res; 2005 Aug 15; 11(16):5793-801. PubMed ID: 16115918
    [Abstract] [Full Text] [Related]

  • 16. EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling.
    Kim YJ, Yoon HY, Kim SK, Kim YW, Kim EJ, Kim IY, Kim WJ.
    Clin Cancer Res; 2011 Jul 01; 17(13):4523-30. PubMed ID: 21571867
    [Abstract] [Full Text] [Related]

  • 17. DNA methylation regulates the expression of Y chromosome specific genes in prostate cancer.
    Dasari VK, Deng D, Perinchery G, Yeh CC, Dahiya R.
    J Urol; 2002 Jan 01; 167(1):335-8. PubMed ID: 11743352
    [Abstract] [Full Text] [Related]

  • 18. Aberrant expression and mutations of TGF-beta receptor type II gene in endometrial cancer.
    Sakaguchi J, Kyo S, Kanaya T, Maida Y, Hashimoto M, Nakamura M, Yamada K, Inoue M.
    Gynecol Oncol; 2005 Sep 01; 98(3):427-33. PubMed ID: 15993480
    [Abstract] [Full Text] [Related]

  • 19. p21WAF1/CIP1 gene is inactivated in metastatic prostatic cancer cell lines by promoter methylation.
    Bott SR, Arya M, Kirby RS, Williamson M.
    Prostate Cancer Prostatic Dis; 2005 Sep 01; 8(4):321-6. PubMed ID: 16276353
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.